Aradhan Chemtech Private Limited

Aradhan Chemtech Private Limited

Pharmaceutical company specializing in processing, refining, and selling drugs and chemicals.
2010 | Hyderabad, Telangana (India) | Inactive

Last Updated:

April 20, 2024
HomeCompanyAradhan Chemtech Private Limited

Who are the key members and board of directors at Aradhan Chemtech?

Executive Team (1)

NameDesignationAppointment DateStatus
Sharat Nalamothu InManaging Director15-Jun-2010Current

Board Members(2)

NameDesignationAppointment DateStatus
Muthyalapati Arjun In Director 26-Jun-2010Current
Vijay Bandla In Whole-Time Director 26-Jun-2010Current

Financial Performance and Corporate Structure Insights of Aradhan Chemtech.

Aradhan Chemtech Private Limited, for the financial year ended 2018, experienced no change in revenue, with a 0% increase. The company also saw a slight decrease in profitability, with a 2.61% decrease in profit. The company's net worth dipped by a decrease of 0.12%.

Revenue Growth Graph
Profit Loss Graph
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metric
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
Revenue from Operations
Total Assets
-0.00%
Profit or Loss
-2.61%
Net Worth
-0.12%
EBITDA

Related Corporates (Common Directorship)

Charges (Loans)

Charges

There are no open charges registered against the company as per our records.

How Many Employees Work at Aradhan Chemtech?

Unlock and access historical data on people associated with Aradhan Chemtech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Graph

Deals i

Rating

Alerts

Latest Updates, News, and FAQs on Aradhan Chemtech

Recent activity within the organization

  • Annual General Meeting

    Aradhan Chemtech Private Limited last Annual general meeting of members was held on 29 Sep 2018 as per latest MCA records.

    29 Sep 2018

  • Balance Sheet

    Aradhan Chemtech Private Limited has filed its annual Financial statements for the year ended 31 Mar 2018 with Roc Hyderabad.

    31 Mar 2018

  • Director Appointment

    Muthyalapati Arjun was appointed as a Director was appointed as a Director on 26 Jun 2010 & has been associated with this company since 14 years 5 months .

    26 Jun 2010

  • Director Appointment

    Vijay Bhaskar Bandla was appointed as a Whole-Time Director was appointed as a Whole-Time Director on 26 Jun 2010 & has been associated with this company since 14 years 5 months .

    26 Jun 2010

  • Director Appointment

    Sharat Nalamothu was appointed as a Managing Director was appointed as a Managing Director on 15 Jun 2010 & has been associated with this company since 14 years 6 months .

    15 Jun 2010

  • Company Incorporation

    Aradhan Chemtech Private Limited was registered on 15 Jun 2010 with Roc Hyderabad & aged 14 years 6 months as per MCA records.

    15 Jun 2010

Frequently asked questions

  • Aradhan Chemtech Private Limited was incorporated on 15 Jun 2010.

  • The authorized share capital of Aradhan Chemtech Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.

  • Currently 3 directors are associated with Aradhan Chemtech Private Limited.

    • Sharat Nalamothu
    • Muthyalapati Arjun
    • Vijay Bhaskar Bandla
  • As per Ministry of Corporate Affairs (Mca), the registered address of Aradhan Chemtech Private Limited is Flat No:104 Plot No:4 & 5 Kavuri Supreme Enclave, Kavuri Hills, Hyderabad, Telangana, India, 500033.

  • The corporate identification number (CIN) of Aradhan Chemtech Private Limited is U24100TG2010PTC068967 and the company number is 068967 as per Ministry of Corporate Affairs (MCA).

  • The Official website of Aradhan Chemtech Private Limited is https://www.aradhan.in

  • The financial reports for the fiscal year 2018 indicates that The net worth of Aradhan Chemtech Private Limited has experienced an downturn of -0.12%.

  • The most recent Balance Sheet for Aradhan Chemtech Private Limited was filed with the ROC on 31 Mar 2018.

Similar Companies Based on Drug Formulation & Development